New hires and promotions in the med-tech industry, including: Glycopath.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accord, Concert, Galera, Henlius, Kinnate, Redhill, Unravel.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aesther, Akamis, Aprea, Arrowhead, Assembly, Calibr, Capricor, Eyenovia, Formosa, Fusion, Gaia, Ipsen, Janssen, J&J, Neurocrine, Nippon Shinyaku, Ocean, Radiomedix, Salarius, Sentia, Talaris, Telix, Theratechnologies, Treefrog, VBL, Xilis.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allovir, Coherus, Cytovation, Dilafor, Dr. Falk, Eluminex, Glycomimetics, Innovent, Junshi, Fortress, Helocyte, Renexxion, Small, VBI, Vyne.

Biopharmas raising money in public or private financings, including: Aera, Avilar, Immunitybio, Transcode.

New hires and promotions in the biopharma industry, including: Adaptimmune, Cue, Enthera, Haya, Kancera, Life, Skye, Tubulis, Vir.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Hologic, Qiagen.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Docsun Biomedical, Future Now Biotech, Electrocore, Eyenovia, Formosa Pharmaceuticals, Guardant Health, Mainz Biomed, Marylebone Lab, Instituto de Microecologia, Masimo, Neotech, Novocure, Vizient.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sera Prognostics.

Med-tech firms raising money in public or private financings, including: Nanite.